Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
2008
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Sequencing and genotypic analysis of the triosephosphate isomerase (TPI1) locus in a large sample of long-lived Germans
2008
Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals
2015
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy
2004
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting
2006
Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review
2021
Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis
2006
Intracerebral haemorrhage
2009 Standout
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Air travel and thrombosis
2002
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
2015
Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity
2008
Regulation of chromatin by histone modifications
2011 Standout
Venous Thromboembolism After Spinal Cord Injury: Incidence, Time Course, and Associated Risk Factors in 16,240 Adults and Children
2005
Early mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency
2013
A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method
2010
Triosephosphate isomerase deficiency: New insights into an enigmatic disease
2009
Antithrombotic Therapy for VTE Disease
2016 Standout
Human Hepatocyte Transplantation: Worldwide Results
2006
Triose Phosphate Isomerase Deficiency Is Caused by Altered Dimerization–Not Catalytic Inactivity–of the Mutant Enzymes
2006
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Triosephosphate isomerase deficiency: historical perspectives and molecular aspects
2000
Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH
2016
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
2007 Standout
Liver biopsy†
2008
Prevention of Venous Thrombosis in Long-Haul Flights with Flite Tabs: The LONFLIT-FLITE Randomized, Controlled Trial
2003
Vascular disorders of the liver # †
2008 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Air Travel and Venous Thromboembolism: A Systematic Review
2007
Prevention of Venous Thrombosis with Elastic Stockings During Long-Haul Flights: The LONFLIT 5 JAP Study
2003
Air travel and thrombosis
2005
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Travel and venous thrombosis
2002
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
2005 Standout
Use of Antithrombotic Agents During Pregnancy
2004
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis
2006
Heparin-Induced Thrombocytopenia
2006 Standout
Comparison of characteristics from White‐ and Black‐Americans with venous thromboembolism: A cross‐sectional study
2010
Valvular Heart Disease and Pregnancy
2005
Prevention of Venous Thromboembolism
2004 Standout
Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study)
2006
Sickle-cell disease
2010 Standout
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2008
Anticoagulation During Pregnancy
2016
Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy
2008
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Thrombosis and cancer
2012
Prevention of Venous Thromboembolism
2008 Standout
Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review
2018
Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice
2010 StandoutNobel
Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves
2006
Neurosteroids: Biosynthesis and Function of These Novel Neuromodulators
2000
The plasma hemostatic proteome: thrombin generation in healthy individuals
2005
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study
2003
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Structural Basis of Human Triosephosphate Isomerase Deficiency
2008
The Pentose Phosphate Pathway Is a Metabolic Redox Sensor and Regulates Transcription During the Antioxidant Response
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2016
Venous thromboembolism in travellers: can we identify those at risk?
2003
Prevention of Venous Thrombosis and Thrombophlebitis in Long-Haul Flights with Pycnogenol®
2004
Inhibition of triosephosphate isomerase by phosphoenolpyruvate in the feedback-regulation of glycolysis
2014
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
How I treat disseminated intravascular coagulation
2017
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
2005
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Cell and tissue engineering for liver disease
2014
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
2009
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
2017 StandoutNobel
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Platelets as Central Actors in Thrombosis—Reprising an Old Role and Defining a New Character
2019
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
2007
Mild hemolytic anemia, progressive neuromotor retardation and fatal outcome: a disorder of glycolysis, triose- phosphate isomerase deficiency.
2013
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Air travel and fatal pulmonary embolism
2006
The Myeloproliferative Disorders
2006
AASLD position paper: Liver biopsy
2008
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
2011
Venous thromboembolism in travellers
2003
Works of Roopen Arya being referenced
Postdischarge venous thromboembolism following hospital admission with COVID-19
2020
Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation
2013
Haemostasis and thrombosis in liver disease
2009
Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin
2001
Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari Syndrome
2006
Risk factors for venous thrombosis in the black population
2003
Evidence for founder effect of the glu104asp substitution and identification of new mutations in triosephosphate isomerase deficiency
1997
Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia
1996
Virchow and his triad: a question of attribution
2008
The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy
2010
Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics
2009
Hepatocyte Transplantation for Inherited Factor VII Deficiency
2004
Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting
2016
Long‐haul flights and deep vein thrombosis: a significant risk only when additional factors are also present
2002
Incidence of genitalChlamydia trachomatisinfection in the male partners attending an infertility clinic
2005
Population Pharmacokinetics of Enoxaparin During the Antenatal Period
2013
Thrombolysis in pregnancy
2003
The current status of bridging anticoagulation
2013
Risk factors for cancer‐associated venous thromboembolism in outpatient deep venous thrombosis clinics
2010
Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy
2002
Prenatal diagnosis of triosephosphate isomerase deficiency
1996
The Molecular Basis of Triosephosphate Isomerase Deficiency
1996
Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia
1996
Evaluating the Performance of a Previously Reported Risk Score To Predict Venous Thromboembolism: A VERITY Registry Study.
2006
Reversal of Metabolic Block in Glycolysis by Enzyme Replacement in Triosephosphate Isomerase–Deficient Cells
1999